Guangzhou Hanfang Launches PharmaGrade Medium Chain Triglyceride

Internationally certified supply solutions for global pharmaceutical excipient buyers

Guangzhou, China – September 15, 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients, today announced the global commercial launch of its injectable-grade medium chain triglyceride product line, designed to address persistent supply chain gaps for pharmaceutical excipient buyers worldwide. The product is built to serve pharmaceutical manufacturers and special medical nutrition producers, with core strengths in stable domestic supply, international regulatory compliance and consistent purity. Through this launch, Guangzhou Hanfang Pharmaceutical Company Limited aims to provide globally accessible, import-substitutable high-end excipients, expanding its footprint in the global pharmaceutical excipient market. The product line is now available for global order placement, with mass production and scheduled shipping starting in late September 2026.

The medium chain triglyceride product line delivers three core value propositions for global clients. First, it provides supply security by leveraging Guangzhou Hanfang Pharmaceutical Company Limited’s dedicated domestic production base, eliminating reliance on single-source imported excipients for long-term formulation projects. Second, it is manufactured using the company’s proprietary integrated green production process, combining supercritical CO2 extraction, membrane separation and chromatographic separation to achieve high purity without residual contaminants from traditional production methods. Third, it is validated for use across injectable emulsion formulations, lipid-based drug delivery systems and special medical nutrition applications, supporting clients across chemical drug, biologic and traditional Chinese medicine manufacturing segments.

To meet global market access requirements, Guangzhou Hanfang Pharmaceutical Company Limited’s medium chain triglyceride product line is supported by a full portfolio of international regulatory certifications, including EU CEP, US FDA US-DMF, Mexico Cofepris and India DCGI registrations. The product complies with quality standards for the EU, North American, Latin American and Asia-Pacific pharmaceutical markets, enabling seamless cross-border supply for multinational pharmaceutical clients.

The medium chain triglyceride product line is now available for global order placement via the company’s official website and authorized international distribution partners, with mass production and global shipping scheduled to begin in late September 2026. In addition to standard product specifications, Guangzhou Hanfang Pharmaceutical Company Limited provides custom processing and technical support services to meet the unique formulation requirements of individual client projects.

“The launch of our globally certified medium chain triglyceride product marks a key milestone in our mission to deliver reliable, domestically produced high-end pharmaceutical excipients to global markets,” said Xu Wendong, General Manager of Guangzhou Hanfang Pharmaceutical Company Limited. “We have invested more than a decade in refining our production technology to match international quality standards, and we are ready to support global clients in building more resilient pharmaceutical supply chains.”

As global pharmaceutical supply chains continue to prioritize supply resilience and multi-source sourcing, demand for certified, domestically produced medium chain triglyceride excipients has grown steadily across major markets. Guangzhou Hanfang Pharmaceutical Company Limited’s entry into this segment aligns with its long-term strategy to reduce global reliance on single-source imported high-end excipients, building on its existing track record of breaking international technology monopolies for injectable-grade egg yolk lecithin and refined olive oil products.

Moving forward, Guangzhou Hanfang Pharmaceutical Company Limited will continue to invest in R&D for high-end pharmaceutical lipid excipients, expanding its global certification portfolio and growing its international distribution network to serve more clients across 30+ countries and regions. The company will also strengthen its technical support capabilities to help global clients integrate its excipient products into their formulation development workflows.

Guangzhou Hanfang Pharmaceutical Company Limited was founded in 1998, as a core state-owned pharmaceutical enterprise under the GPHL group, focused on the R&D, production and distribution of high-end pharmaceutical lipid excipients, specialty oncology active pharmaceutical ingredients, and health products. Headquartered in Guangzhou, China, the company operates a dedicated production base in Conghua, Guangzhou, with R&D centers in Guangzhou’s Haizhu district and Zhuhai’s Hengqin zone. The company serves more than 1000 clients across 30+ countries, holding over 240 patents, and has earned national-level recognitions including the national specialized and sophisticated “little giant” enterprise designation, National May 1 Labor Award, and National Green Factory certification. The company’s mission is to advance technological self-reliance in the pharmaceutical sector, breaking through “chokepoint” technology barriers to support global pharmaceutical supply chain security. More information is available at http://byshanhanfang.com/.

FAQ

Q: What international certifications does Guangzhou Hanfang Pharmaceutical Company Limited’s medium chain triglyceride product hold?
A: The product line is supported by EU CEP, US FDA US-DMF, Mexico Cofepris and India DCGI registrations, meeting quality requirements for major global pharmaceutical markets.

Q: What applications is Guangzhou Hanfang Pharmaceutical Company Limited’s medium chain triglyceride suitable for?
A: The product can be used as an active pharmaceutical ingredient, solvent and emulsifier for injectable formulations, as well as a core raw material for special medical nutrition products.

Contact Us

Official Website: http://byshanhanfang.com/
Headquarters Address: No.134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, Guangdong, China
Production Base Address: No.8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong, China